> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Oramed Starts Second Phase 3 Insulin Capsule Trial
- URL: https://www.fdaweb.com/oramed-starts-second-phase-3-insulin-capsule-trial/
- Published: 2021-03-23T12:00:00.000Z
- Updated: 2026-09-14T16:51:54.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5148937

Oramed Pharmaceuticals says it has screened the first patients for the second of two concurrent Phase 3 studies of its ORMD-0801 oral insulin capsule for treating Type 2 diabetes. The company [says](https://www.biospace.com/article/releases/oramed-initiates-second-phase-3-oral-insulin-study-under-the-fda-s-approved-dual-concurrent-protocol/?ref=fdaweb.com) the studies are being conducted under an FDA-approved protocol to treat Type 2 diabetes patients who have inadequate glycemic control over six to 12 months. Enrollment for the other Phase 3 study is ongoing, Oramed says.

The company says that 1,125 patients will be recruited to evaluate the drug’s efficacy and safety.